A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection.

MLA

Bernasconi, Valentina, et al. “A Vaccine Combination of Lipid Nanoparticles and a Cholera Toxin Adjuvant Derivative Greatly Improves Lung Protection against Influenza Virus Infection.” Mucosal Immunology, vol. 14, no. 2, Mar. 2021, pp. 523–36. EBSCOhost, https://doi.org/10.1038/s41385-020-0334-2.

APA

Bernasconi, V., Norling, K., Gribonika, I., Ong, L. C., Burazerovic, S., Parveen, N., Schön, K., Stensson, A., Bally, M., Larson, G., Höök, F., & Lycke, N. (2021). A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection. Mucosal Immunology, 14(2), 523–536. https://doi.org/10.1038/s41385-020-0334-2

Chicago

Bernasconi, Valentina, Karin Norling, Inta Gribonika, Li Ching Ong, Sabina Burazerovic, Nagma Parveen, Karin Schön, et al. 2021. “A Vaccine Combination of Lipid Nanoparticles and a Cholera Toxin Adjuvant Derivative Greatly Improves Lung Protection against Influenza Virus Infection.” Mucosal Immunology 14 (2): 523–36. doi:10.1038/s41385-020-0334-2.